Qiuhe Ji

7.4k total citations · 1 hit paper
75 papers, 4.2k citations indexed

About

Qiuhe Ji is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Qiuhe Ji has authored 75 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Qiuhe Ji's work include Diabetes Treatment and Management (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Diabetes Management and Research (19 papers). Qiuhe Ji is often cited by papers focused on Diabetes Treatment and Management (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Diabetes Management and Research (19 papers). Qiuhe Ji collaborates with scholars based in China, United States and Poland. Qiuhe Ji's co-authors include Wenying Yang, Weiping Jia, Zhiguang Zhou, Jianping Weng, Haoming Tian, Zhongyan Shan, Juming Lu, Dalong Zhu, Jiapu Ge and Li Chen and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Qiuhe Ji

73 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Diabetes among Men and Women in China

2010 2.5k citations Wenying Yang, Juming Lu et al. profile →

Peers

Countries citing papers authored by Qiuhe Ji

Since Specialization

Citations

This map shows the geographic impact of Qiuhe Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuhe Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuhe Ji more than expected).

Fields of papers citing papers by Qiuhe Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuhe Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuhe Ji. The network helps show where Qiuhe Ji may publish in the future.

Co-authorship network of co-authors of Qiuhe Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuhe Ji. A scholar is included among the top collaborators of Qiuhe Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuhe Ji. Qiuhe Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China) 2025 ·Advances in Therapy ·Xiaoling Cai, Wen‐Jia Yang, Bo Feng, Qiuhe Ji, Ming Liu, Yanbing Li, Nanwei Tong, (unknown), Minghui Zhao, Linong Ji	0
2	Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database 2024 ·Frontiers in Endocrinology ·Qiuhe Ji, (unknown), Ruya Zhang, Jihu Li, (unknown), Swapnil Rajpathak	6
3	Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study 2023 ·Journal of Diabetes Research ·Jianfang Fu, (unknown), (unknown), (unknown), (unknown), Jianrong Liu, (unknown), (unknown), (unknown), (unknown), (unknown), Mengying Li, Jie Ming, Qiuhe Ji	8
4	Serum uric acid to high-density lipoprotein cholesterol ratio is a promising marker for identifying metabolic syndrome in nondiabetic Chinese men 2023 ·Postgraduate Medicine ·(unknown), (unknown), (unknown), Shengru Liang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bin Gao, Qiuhe Ji	18
5	Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China 2023 ·Diabetes/Metabolism Research and Reviews ·(unknown), Qiuhe Ji, Xingwu Ran, (unknown), Hongyu Kuang, Xuefeng Yu, Hui Fang, Jing Yang, Jing Liu, Yaoming Xue, (unknown), Minxiang Lei, Dalong Zhu	43
6	Thyroid autoantibody distribution in patients with latent autoimmune diabetes in youth: a multicenter, national survey 2022 ·Annals of Translational Medicine ·(unknown), Xia Li, Yufei Xiang, Xiang Yan, Hou‐De Zhou, Xiao‐Han Tang, Cheng Jin, Xiaohong Niu, Jing Liu, Qiuhe Ji, Linong Ji, Gan Huang, Zhiguang Zhou	3
7	Association between Obstructive Sleep Apnea and Type 2 Diabetes Mellitus: A Dose-Response Meta-Analysis 2021 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Jinxiang Cheng, Dong Zhang, (unknown), Qiuhe Ji	21
8	Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages 2021 ·Diabetes Technology & Therapeutics ·(unknown), Xia Li, Yufei Xiang, Xiang Yan, Hou‐De Zhou, Xiao‐Han Tang, (unknown), Xiaohong Niu, Jing Liu, Qiuhe Ji, Linong Ji, Gan Huang, Zhiguang Zhou	6
9	Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study 2021 ·Genome Medicine ·Jie Ming, Xinwen Yu, Xiaoqiang Xu, Li Wang, Chao Ding, Zhifeng Wang, (unknown), (unknown), Wenjuan Yang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yujie Fang, Chen Li, Jiajun Zhao, Xiaokai Wang, Qiuhe Ji	41
10	Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice 2021 ·Stem Cell Research & Therapy ·Binghua Xue, (unknown), Tingting Yu, (unknown), Jing Xie, Qiuhe Ji, Li Wang, Tao Na, Shufang Meng, Lingjia Qian, Haifeng Duan	19
11	<p>Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes</p> 2019 ·Diabetes Metabolic Syndrome and Obesity ·Xiao‐Han Tang, Xiang Yan, Hou‐De Zhou, Xilin Yang, Xiaohong Niu, Jing Liu, Qiuhe Ji, Linong Ji, Xia Li, Zhiguang Zhou	29
12	Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population 2018 ·Diabetes Therapy ·Fei Sun, Bin Gao, Li Wang, Ying Xing, Jie Ming, Jie Zhou, Jianfang Fu, (unknown), Shaoyong Xu, Guocai Liu, Qiuhe Ji	6
13	Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial 2017 ·Science China Life Sciences ·Wen Xu, Yiming Mu, Jiajun Zhao, Dalong Zhu, Qiuhe Ji, Zhiguang Zhou, Bin Yao, (unknown), Samuel S. Engel, Bin Zhao, Yan Bi, Longyi Zeng, Xingwu Ran, Juming Lu, Linong Ji, Wenying Yang, Weiping Jia, Jianping Weng	8
14	Effectiveness evaluation of the mobile health patients management mode on treatment compliance and glycemic control for type 2 diabetes patients using basal insulin treatment for 12 weeks 2016 ·Zhonghua neifenmi daixie zazhi ·Xiaohui Guo, Liming Chen, (unknown), Qiuhe Ji, Zilin Sun, Qiang Li, (unknown), Fang Zhao, Yuan Li, Qingqing Lou, (unknown), Dandan Qin	3
15	Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study 2016 ·PLoS ONE ·Xianghai Zhou, Linong Ji, Xingwu Ran, Benli Su, Qiuhe Ji, Changyu Pan, Jianping Weng, Changsheng Ma, Chuan‐Ming Hao, Danyi Zhang, Dayi Hu, (unknown)	37
16	Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial 2015 ·The Lancet Diabetes & Endocrinology ·Weiping Jia, Xinhua Xiao, Qiuhe Ji, Kyu Jeung Ahn, Lee‐Ming Chuang, Yuqian Bao, Can Pang, Lei Chen, Fei Gao, Yinfang Tu, Pengfei Li, (unknown)	33
17	Cost-effectiveness of insulin aspart and human soluble insulin for treatment of type 2 diabetes 2014 ·Zhongguo xin yao zazhi ·Zhangrong Xu, Qiuhe Ji, (unknown), Qing Ye	1
18	Hyperglycemia and Blood Pressure Treatment Goal: A Cross Sectional Survey of 18350 Patients with Type 2 Diabetes in 77 Tertiary Hospitals in China 2014 ·PLoS ONE ·Linong Ji, Xinyue Zhi, Juming Lu, Xiaohui Guo, Wenying Yang, Weiping Jia, Dajin Zou, Zhiguang Zhou, Qiuhe Ji, Dalong Zhu, Lixin Shi, Jianping Weng	2
19	Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial 2013 ·The Lancet Diabetes & Endocrinology ·Wenying Yang, Jie Liu, Zhongyan Shan, Haoming Tian, Zhiguang Zhou, Qiuhe Ji, Jianping Weng, Weiping Jia, Juming Lu, Jing Liu, Yuan Xu, Zhaojun Yang, Wei Chen	128
20	Free Fatty Acid Induces Endoplasmic Reticulum Stress and Apoptosis of β-cells by Ca2+/Calpain-2 Pathways 2013 ·PLoS ONE ·(unknown), Jie Ma, Xingqin Wang, Wenjuan Yang, Jing Zhang, Qiuhe Ji	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact